May 24, 2020
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
Mar 23, 2020
Pliant Therapeutics Initiates First-in-Human Clinical Trial of PLN-1474 for the Potential Treatment of Liver Fibrosis
Mar 05, 2020
Zydus Announces World's First Drug for the Treatment of Non-Cirrhotic NASH
Jan 13, 2020
Akero Therapeutics Expands Phase 2a Trial in NASH to Include Cohort of Cirrhotic Patients
Nov 21, 2019
Elysium Health(TM) Announces Clinical Trial to Explore the Effect of Basis(TM) on Liver Fat Accumulation in Healthy Adults with Fatty Liver (NAFL)
Nov 07, 2019
Hepatic Encephalopathy Epidemiology Report 2019: Total Prevalent Case in the 7MM were Approx 525,000 in 2017 - Forecast to 2028
Oct 31, 2019
Pliant Therapeutics to Present Preclinical Data in Primary Sclerosing Cholangitis at The Liver Meeting 2019
Oct 31, 2019
Sirnaomics to Present Preclinical STP705 Data Suggesting Reduction in Liver Fibrosis at AASLD Liver Meeting
Oct 03, 2019
Zydus Announces Positive Results From EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NAFLD and NASH
Aug 28, 2019
FDA In Brief: FDA warns patients and health care professionals about rare instances of serious liver injury or failure with certain hepatitis C treatments in some patients with advanced liver disease
Aug 12, 2019
First Patient Enrolled in Mallinckrodt's Phase 2a Study of Investigational Drug MNK-6106 in Hepatic Cirrhosis and Chronic Hepatic Encephalopathy (HE)
Aug 08, 2019
Laboratory for Advanced Medicine Strengthens Hepatology Board with Addition of Three Distinguished Medical Doctors
Jun 27, 2019
Pliant Therapeutics Reports Positive Results of Phase 1b Clinical Study Supporting Advancement of PLN-74809 for Treatment of Idiopathic Pulmonary Fibrosis
Jun 17, 2019
Zydus Announces Completion of Enrolment in EVIDENCES IV Phase 2 Clinical Trial of Saroglitazar Magnesium in NASH
Jun 11, 2019
NASH kNOWledge Joins Global International Nonalcoholic Steatohepatitis (NASH) DAY to Raise Disease Awareness
May 22, 2019
Scientists Identify New Therapeutic Target for Fatty Liver Disease
Apr 15, 2019
Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress(TM) (EASL)
Mar 28, 2019
Pliant Therapeutics Presents Data in Human NASH Liver Tissue at The International Liver Congress 2019 Hosted by the European Association for the Study of the Liver (EASL)
Feb 28, 2019
Stero Biotechs to Commence Phase 2 Clinical Trial of ST-AH-01 Cannabidiol Formulation for Ground Breaking Maintenance Therapy and Steroid Reduction in Patients With Autoimmune Hepatitis
Feb 18, 2019
The global liver cancer diagnostics market size is expected to reach USD 15.4 billion by 2025